Knight Therapeutics (GUD) News Today

C$6.11
-0.03 (-0.49%)
(As of 05/17/2024 ET)
GUD:CA Knight Therapeutics Inc.
Knight Therapeutics (TSE:GUD) Reaches New 52-Week High at $6.17
Knight Therapeutics (TSE:GUD) Reaches New 12-Month High at $6.17
Knight Therapeutics (TSE:GUD) PT Raised to C$5.75
Stifel Nicolaus Increases Knight Therapeutics (TSE:GUD) Price Target to C$5.75
Stifel Nicolaus lifted their price objective on shares of Knight Therapeutics from C$5.40 to C$5.75 in a research report on Friday.
Knight Therapeutics (TSE:GUD) Reaches New 12-Month High at $5.95
Knight Therapeutics (TSE:GUD) Reaches New 12-Month High at $5.95
Knight Therapeutics (GUD) to Release Quarterly Earnings on Thursday
Knight Therapeutics (TSE:GUD) will be releasing earnings before the market opens on Thursday, May 9, Zacks reports.
Knight Therapeutics (TSE:GUD) PT Raised to C$5.40
Stifel Nicolaus lifted their price target on shares of Knight Therapeutics from C$5.25 to C$5.40 and gave the company a "hold" rating in a research report on Wednesday.
Knight Therapeutics Inc (GUD)
Sime Armoyan Sells 10,900 Shares of Knight Therapeutics Inc. (TSE:GUD) Stock
Knight Therapeutics Inc. (TSE:GUD - Get Free Report) insider Sime Armoyan sold 10,900 shares of Knight Therapeutics stock in a transaction dated Thursday, April 11th. The stock was sold at an average price of C$5.95, for a total transaction of C$64,855.00.
Knight Therapeutics (TSE:GUD) Reaches New 1-Year High at $5.80
Knight Therapeutics (TSE:GUD) Hits New 1-Year High at $5.80
Insider Buying: Knight Therapeutics Inc. (TSE:GUD) Insider Purchases 6,200 Shares of Stock
Knight Therapeutics Inc. (TSE:GUD - Get Free Report) insider Sime Armoyan bought 6,200 shares of the company's stock in a transaction on Monday, April 1st. The shares were acquired at an average price of C$5.25 per share, with a total value of C$32,550.00.
Knight Therapeutics Inc. (TSE:GUD) Insider Sime Armoyan Buys 351,000 Shares
Knight Therapeutics Inc. (TSE:GUD - Get Free Report) insider Sime Armoyan bought 351,000 shares of the company's stock in a transaction dated Monday, March 25th. The stock was acquired at an average price of C$5.25 per share, for a total transaction of C$1,842,750.00.
Royal Bank of Canada Raises Knight Therapeutics (TSE:GUD) Price Target to C$7.00
Royal Bank of Canada increased their price target on shares of Knight Therapeutics from C$6.50 to C$7.00 and gave the company an "outperform" rating in a research report on Friday.
Knight Therapeutics Inc (04K.SG)
Stocks in play: Knight Therapeutics Inc.
Raymond James Research Analysts Increase Earnings Estimates for Knight Therapeutics Inc. (TSE:GUD)
Knight Therapeutics Inc. (TSE:GUD - Free Report) - Research analysts at Raymond James raised their FY2026 earnings estimates for shares of Knight Therapeutics in a research report issued on Wednesday, March 6th. Raymond James analyst R. Sarugaser now anticipates that the company will post earning
Analysts Offer Predictions for Knight Therapeutics Inc.'s Q4 2023 Earnings (TSE:GUD)
Knight Therapeutics Inc. (TSE:GUD - Free Report) - Equities researchers at Raymond James issued their Q4 2023 EPS estimates for Knight Therapeutics in a report released on Wednesday, February 28th. Raymond James analyst R. Sarugaser anticipates that the company will post earnings of $0.00 per sha
Stocks in play: Knight Therapeutics Inc.,
Brokers Issue Forecasts for Knight Therapeutics Inc.'s FY2023 Earnings (TSE:GUD)
Knight Therapeutics Inc. (TSE:GUD - Free Report) - Stock analysts at Raymond James issued their FY2023 earnings per share estimates for Knight Therapeutics in a research report issued on Wednesday, February 28th. Raymond James analyst R. Sarugaser anticipates that the company will post earnings p
Insider Selling: Knight Therapeutics Inc. (TSE:GUD) Insider Sells 28,200 Shares of Stock
Knight Therapeutics Inc. (TSE:GUD - Get Free Report) insider Sime Armoyan sold 28,200 shares of the business's stock in a transaction that occurred on Monday, January 22nd. The shares were sold at an average price of C$5.75, for a total value of C$162,150.00.
Knight Therapeutics Inc. (TSE:GUD) Insider Sime Armoyan Sells 91,000 Shares
Knight Therapeutics Inc. (TSE:GUD - Get Free Report) insider Sime Armoyan sold 91,000 shares of the stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of C$5.75, for a total value of C$523,250.00.
Closing Bell: Knight Therapeutics Inc flat on Thursday (GUD)
Knight Therapeutics (KHTRF) Receives a Buy from RBC Capital
Knight Therapeutics Reports Second Quarter 2023 Results
Get Knight Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GUD and its competitors with MarketBeat's FREE daily newsletter.

Elon’s New Device is About to Shock the World (Ad)

Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”

Click here to see the details because there’s a lot of money at stake.

GUD Media Mentions By Week

GUD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GUD
News Sentiment

0.05

0.42

Average
Medical
News Sentiment

GUD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GUD Articles
This Week

2

0

GUD Articles
Average Week

Get Knight Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GUD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (TSE:GUD) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners